Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …

Stroke can be categorized as ischemic stroke, intracerebral hemorrhage, or subarachnoid
hemorrhage. Awakening with or experiencing the abrupt onset of focal neurologic deficits is …

Background and Purpose—Intravenous thrombolysis for acute ischemic stroke is beneficial
within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating …

Background and Purpose—Shortening door-to-needle time may lead to inadvertent
intravenous thrombolysis (IVT) administration in stroke mimics (SMs). We sought to …

It is estimated that 795,000 persons have a stroke each year in the United States, causing
140,000 deaths. 1, 2 That said, stroke has moved from the third leading cause of death in …

Background and Purpose—Orolingual angioedema (OLAE) is a life-threatening
complication of intravenous thrombolysis. Our objective was to compare outcomes of …

Abstract Background Current American Stroke Association guidelines recommend initiating
intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) within 60 min of patient arrival …

Background: The necessity for rapid evaluation and treatment of acute ischemic stroke with
intravenous tPA (tissue-type plasminogen activator) may increase the risk of administrating …

Objective To study the diagnostic value of volume perfusion CT (VPCT) in patients with
transient focal neurologic deficits following and during epileptic seizures, that mimic …

Background Migraine with aura may mimic an acute ischemic stroke, so that an improper
administration of thrombolytic treatment can expose migrainous patients to severe adverse …